July 17, 2024

		


| Thursday, February 19th, 2015

CNB heats up banking wars

Banking & Finance, Banking Industry, Latest news, Top Stories

City National Bank has become the newest entrant in the competitive Santa Barbara banking market.

| Tuesday, February 17th, 2015

Board says it ousted Sorensen from Select Staffing

Latest news, Top Stories

D. Stephen Sorensen, who steered the fortunes of Santa Barbara-based Select Staffing through explosive growth, bankruptcy and a merger that closed on Feb. 9, has been terminated for cause.

| Monday, February 9th, 2015

REC Solar sells majority share to nation’s largest utility

Central Coast, Latest news, Technology, Top Stories

Duke Energy, headquartered in Charlotte, North Carolina, purchased the controlling stake in the solar company and announced it would invest $225 million in solar project financing as part of the deal.

| Monday, February 9th, 2015

Milstien signs on as head of VCHC

Health Care & Life Science, Latest news, Top Stories

Ventura County Health Center announced today that Kimberly Milstien will succeed Barry Fisher as its next CEO. She will assume the position March 1.

| Friday, February 6th, 2015

Botanical Garden grows donations, announces new staff

Latest news, Nonprofits, Top Stories

The Santa Barbara Botanical Gardens created its first endowed position and will renovate flora with the $15 million raised through its Seed the Future campaign.

| Tuesday, February 3rd, 2015

Heritage Oaks Q4 profits jump 24%

Banking & Finance, Banking Industry, Central Coast, Latest news, Top Stories

The increase was primarily due to the inclusion of Mission Community Bancorp’s operating results, which boosted pre-tax net income in the company’s fourth quarter financials.

| Friday, January 30th, 2015

Amgen profit tops analysts’ estimates on drug sales, tax credit

East Ventura County, Health Care & Life Science, Latest news, Subscriber content, Technology, Top Stories, Tri-County Public Companies

Amgen, the nation’s biggest biotech company, reported fourth-quarter profits that beat analysts’ estimates, aided by a tax benefit and higher-than-estimated sales of arthritis drug Enbrel.